Abstract
This article reviews the assessment and treatment for depression in children and adolescents, emphasizing the implementation of evidence-based treatments into clinical care. Past trials of antidepressant medications are reviewed, as well as the clinical use of antidepressants and pharmacologic strategies for refractory illness or in the context of comorbid conditions. Clinicians who treat youth now have a body of empiric research to help guide treatment decisions; however, personalized treatment based on associated symptoms, comorbid conditions, contextual factors, and psychiatric history is essential. Further research is needed in the pharmacologic treatment of depressed youth, including expanding the study of non-SSRI antidepressants, augmentation and adjunctive strategies, and treatment in patients with comorbid conditions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 807-829 |
| Number of pages | 23 |
| Journal | Child and Adolescent Psychiatric Clinics of North America |
| Volume | 21 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2012 |
Fingerprint
Keywords
- Antidepression treatment
- Depression
- MDD
- Psychopharmacotherapy
- Youth depression
ASJC Scopus subject areas
- Psychiatry and Mental health
- Pediatrics, Perinatology, and Child Health
Cite this
Depression. / Choe, Christine J.; Emslie, Graham J.; Mayes, Taryn L.
In: Child and Adolescent Psychiatric Clinics of North America, Vol. 21, No. 4, 10.2012, p. 807-829.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Depression
AU - Choe, Christine J.
AU - Emslie, Graham J.
AU - Mayes, Taryn L.
PY - 2012/10
Y1 - 2012/10
N2 - This article reviews the assessment and treatment for depression in children and adolescents, emphasizing the implementation of evidence-based treatments into clinical care. Past trials of antidepressant medications are reviewed, as well as the clinical use of antidepressants and pharmacologic strategies for refractory illness or in the context of comorbid conditions. Clinicians who treat youth now have a body of empiric research to help guide treatment decisions; however, personalized treatment based on associated symptoms, comorbid conditions, contextual factors, and psychiatric history is essential. Further research is needed in the pharmacologic treatment of depressed youth, including expanding the study of non-SSRI antidepressants, augmentation and adjunctive strategies, and treatment in patients with comorbid conditions.
AB - This article reviews the assessment and treatment for depression in children and adolescents, emphasizing the implementation of evidence-based treatments into clinical care. Past trials of antidepressant medications are reviewed, as well as the clinical use of antidepressants and pharmacologic strategies for refractory illness or in the context of comorbid conditions. Clinicians who treat youth now have a body of empiric research to help guide treatment decisions; however, personalized treatment based on associated symptoms, comorbid conditions, contextual factors, and psychiatric history is essential. Further research is needed in the pharmacologic treatment of depressed youth, including expanding the study of non-SSRI antidepressants, augmentation and adjunctive strategies, and treatment in patients with comorbid conditions.
KW - Antidepression treatment
KW - Depression
KW - MDD
KW - Psychopharmacotherapy
KW - Youth depression
UR - http://www.scopus.com/inward/record.url?scp=84867060982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867060982&partnerID=8YFLogxK
U2 - 10.1016/j.chc.2012.07.002
DO - 10.1016/j.chc.2012.07.002
M3 - Article
C2 - 23040903
AN - SCOPUS:84867060982
VL - 21
SP - 807
EP - 829
JO - Child and Adolescent Psychiatric Clinics of North America
JF - Child and Adolescent Psychiatric Clinics of North America
SN - 1056-4993
IS - 4
ER -